In 2020, the CAA completed 41 accreditation application reviews of graduate academic programs (11 clinical doctoral programs in audiology, 30 master’s programs in speech-language pathology), including reviews of applications for candidacy. Additionally, the CAA reviewed 3 substantive changes and 4 end of probation reports. The CAA also reviewed annual reports from 239 graduate academic programs (53 clinical doctoral programs in audiology, 186 master's programs in speech-language pathology).
The CAA’s 2020 accreditation reviews resulted in the following accreditation decisions:
Accreditation status decisions (e.g., award accreditation, place on probation) are made public in accordance with the CAA’s Public Notice of Accreditation Actions policy. CAA’s policy and descriptions of those decisions can be found in the Accreditation Handbook—Chapter XII: Informing the Public.
The areas (2017 standards) the CAA most frequently cited programs for noncompliance in 2020 as the result of initial and re-accreditation application reviews included:
Of note, there were 17 graduate academic programs that received no citations (e.g., no areas of noncompliance and no areas for follow-up) as a result of their initial or re-accreditation application reviews in 2020.
The areas (2017 standards) the CAA most frequently cited programs for noncompliance in 2020 as the result of annual report reviews included:
*As in previous years, a little over a third of the programs submitting annual reports for CAA review in 2020 were cited for non-compliance under Standard 1.9. Further, of the citations under Standard 1.9, almost half were for “inaccuracy of accreditation statement” (e.g., not using the CAA-specified language and components). While most of the other citations under this standard were for “incomplete and inaccurate student achievement data” (e.g., missing the most recently completed academic year’s data or mislabeled on the program website). Also of note, there were 108 graduate academic programs that received no citations (e.g., no areas of noncompliance and no areas for follow-up) as a result of their annual report reviews in 2020.